Extracted from this filing and checked against the source text.
Debt Financings
SEC 8-K Item 2.03/2.04
confidence 0.9
Onconetix, Inc. incurred loan of aggregate principal amount of $147,058.82 with Keystone Capital Partners, LLC at does not initially bear interest maturing March 5, 2026.
- Instrument
- loan
- Principal
- aggregate principal amount of $147,058.82
- Counterparty
- Keystone Capital Partners, LLC
- Rate
- does not initially bear interest
- Maturity
- March 5, 2026
- Event
- incurrence
Exact text from the filing
issued a promissory note to Keystone Capital Partners, LLC with original issue discount of $22,058.82, in an aggregate principal amount of $147,058.82. The note is due and payable upon the earlier of (i) the Company’s receipt of sufficient proceeds from the ELOC and (ii) March 5, 2026
View on SEC.gov
Governance Changes
SEC 8-K Item 5.03/5.05/5.06
confidence 0.9
Onconetix, Inc.: Amendment to Amended and Restated Certificate of Incorporation to effect a 1-for-85 reverse stock split (effective 2025-06-13).
- Change
- charter amendment
- Effective
- 2025-06-13
Exact text from the filing
On June 11, 2025, the Company expects to file the Amendment to its Charter with the Secretary of State of the State of Delaware to effect a reverse stock split of its Common Stock at a ratio of 1-to-85 (the "Reverse Stock Split"). The Reverse Stock Split will become effective in accordance with the terms of the Amendment at 12:01 a.m. Eastern Time on June 13, 2025 (the "Effective Time").
View on SEC.gov